Back to AERIView full pipeline
Phase 3
Development Phase
0
Upcoming Catalysts
0
Historical Events
0
Regulatory Approvals
No Catalysts Found
No catalyst events have been recorded for this drug yet.
Competitive Landscape
0 competitors in Ocular Hypertension
View Full LandscapeDrug Information
Patent & Exclusivity
No patent data available. Pre-approval drugs may not have Orange Book listings.
Drug Science
Mechanism of action & safety profile
Related Pipeline
Netarsudil ophthalmic solution 0.02%Phase 3
Primary Open Angle Glaucoma
Timolol maleate Ophthalmic Solution 0.5% BIDPhase 3
Ocular Hypertension
Latanoprost ophthalmic solution 0.005%Phase 3
Ocular Hypertension
Netarsudil/Latanoprost 0.02%/0.005%Phase 3
Open Angle Glaucoma
0.003% AR-15512 ophthalmic solutionPhase 3
Dry Eye Disease
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts